Table of Contents
ISRN Oncology
Volume 2012, Article ID 439070, 9 pages
http://dx.doi.org/10.5402/2012/439070
Clinical Study

Sex Variability in Pediatric Leukemia Survival: Large Cohort Evidence

1American Health Research Institute, Heights Medical Tower, Houston, TX 77008, USA
2Nemours Center for Childhood Cancer Research, Wilmington, DE 19803, USA
3Orthopedic Department, Epidemiology & Biostatistics Section, A.I.duPont Hospital for Children, Wilmington, DE 19803, USA
4University of Delaware, Newark, DE 19716, USA
5Biomedical Research Department, A.I.duPont Hospital for Children, Wilmington, DE 19803, USA
6Texas A & M University, Houston, TX 77030, USA

Received 5 December 2011; Accepted 15 January 2012

Academic Editors: H. U. Gali-Muhtasib and H. M. Warenius

Copyright © 2012 L. Holmes Jr. et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “SEER cancer statistics review 1975–2006, NCI”.
  2. R. M. Hardisty, H. E. M. Kay, and J. Peto, “Effects of varying radiation schedule, cyclophosphamide treatment, and duration of treatment in acute lymphoblastic leukaemia,” The British Medical Journal, vol. 2, no. 6140, pp. 787–791, 1978. View at Google Scholar · View at Scopus
  3. H. Sather, D. Miller, M. Nesbit, R. Heyn, and D. Hammond, “Differences in prognosis for boys and girls with acute lymphoblastic leukaemia,” The Lancet, vol. 317, no. 8223, pp. 739–743, 1981. View at Publisher · View at Google Scholar · View at Scopus
  4. The Medical Research Council’s Working Party on Leukaemia in Childhood, “Duration of chemotherapy in childhood acute lymphoblastic leukemia,” Medical and Pediatric Oncology, vol. 10, no. 5, pp. 511–520, 1982. View at Google Scholar
  5. R. J. Stockley, P. Y. Ahlquist, and M. G. Mott, “A good prognosis is group in childhood acute lymphoblastic leukaemia,” British Journal of Haematology, vol. 55, no. 2, pp. 257–261, 1983. View at Google Scholar · View at Scopus
  6. G. Gustafsson and A. Kreuger, “Sex and other prognostic factors in acute lymphoblastic leukemia in childhood,” Journal of Pediatric Hematology/Oncology, vol. 5, no. 3, pp. 243–250, 1983. View at Google Scholar · View at Scopus
  7. M. E. Nesbit Jr., H. N. Sather, L. L. Robison, J. A. Ortega, and G. D. Hammond, “Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 1, no. 5, pp. 308–316, 1983. View at Google Scholar
  8. J. M. Chessells, J. Durrant, R. M. Hardy, and S. Richards, “Medical Research Council Leukaemia Trial: UKALL V—an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 4, no. 12, pp. 1758–1764, 1986. View at Google Scholar
  9. C. H. Pui, S. C. Raimondi, R. K. Dodge et al., “Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (.50 chromosomes) acute lymphoblastic leukemia,” Blood, vol. 73, no. 7, pp. 1963–1967, 1989. View at Google Scholar · View at Scopus
  10. K. Foucar, M. H. Duncan, C. A. Stidley, C. L. Wiggins, W. C. Hunt, and C. R. Key, “Survival of children and adolescents with acute lymphoid leukemia: a study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986),” Cancer, vol. 67, no. 8, pp. 2125–2130, 1991. View at Google Scholar · View at Scopus
  11. W. A. Bleyer, H. N. Sather, H. J. Nickerson, P. F. Coccia, J. Z. Finklestein, D. R. Miller et al., “Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 9, no. 6, pp. 1012–1021, 1991. View at Google Scholar · View at Scopus
  12. M. Lanning, S. Garwicz, H. Hertz, G. Jonmundsson, A. Kreuger, S. O. Lie et al., “Superior treatment results in females with high-risk acute lymphoblastic leukemia in childhood,” Acta Paediatrica, vol. 8, no. 1, pp. 66–68, 1992. View at Google Scholar · View at Scopus
  13. D. G. Tubergen, G. S. Gilchrist, R. T. O'Brien, P. F. Coccia, H. N. Sather, M. G. Waskerwitz et al., “Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features,” American Society of Clinical Oncology, vol. 11, no. 3, pp. 527–537, 1993. View at Google Scholar · View at Scopus
  14. A. Reiter, M. Schrappe, W. D. Ludwig, W. Hiddemann, S. Sauter, G. Henze et al., “Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86,” Blood, vol. 84, no. 9, pp. 3122–3133, 1994. View at Google Scholar · View at Scopus
  15. P. Imbach, A. Fushs, W. Berchtold, B. Arnet, A. Stupnici, R. Angst et al., “Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL: population-based data results of initial prognostic factors and long-term event-free survival,” Journal of Pediatric Hematology/Oncology, vol. 17, no. 4, pp. 346–349, 1995. View at Google Scholar · View at Scopus
  16. J. M. Chessells, S. M. Richards, C. C. Bailey, J. S. Lilleyman, and O. B. Eden, “Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials,” British Journal of Haematology, vol. 89, no. 2, pp. 364–372, 1995. View at Google Scholar · View at Scopus
  17. J. J. Shuster, P. Wacker, J. Pullen, J. Humbert, V. J. Land, D. H. Mahoney Jr. et al., “Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a pediatric oncology group study,” Journal of Clinical Oncology, vol. 16, no. 8, pp. 2854–2863, 1998. View at Google Scholar · View at Scopus
  18. “Surveillance, epidemiology and end results (SEER) program web site, data quality,” 2003, http://www.seer.cancer.gov/about/quality.html.
  19. L. Holmes Jr., C. Escalante, O. Garrison, B. X. Foldi, G. O. Ogungbade, E. J. Essien et al., “Testicular cancer incidence trends in the USA (1975–2004): plateau or shifting racial paradigm?” Public Health, vol. 122, no. 9, pp. 862–872, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Holmes Jr., W. Chan, Z. Jiang, and X. L. Du, “Effectiveness of androgen deprivation therapy in prolonging survival of older men treated for locoregional prostate cancer,” Prostate Cancer and Prostatic Diseases, vol. 10, no. 4, pp. 388–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. X. L. Du, J. L. Freeman, and J. S. Goodwin, “Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data,” Journal of Clinical Epidemiology, vol. 52, no. 5, pp. 463–470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. C. H. Pui, J. M. Boyett, M. V. Relling, P. L. Harrison, G. K. Rivera, F. G. Behm et al., “Sex differences in prognosis for children with acute lymphoblastic leukemia,” Journal of Clinical Oncology, vol. 17, no. 3, pp. 818–824, 1999. View at Google Scholar · View at Scopus
  23. L. Holmes Jr., W. Chan, Z. Jiang, D. Ward, E. J. Essien, and X. L. Du, “Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer,” Cancer Control, vol. 16, no. 2, pp. 176–185, 2009. View at Google Scholar · View at Scopus
  24. B. H. Pollock, M. R. DeBaun, B. M. Camitta, J. J. Shuster, Y. Ravindranath, D. J. Pullen et al., “Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a pediatric oncology group study,” Journal of Clinical Oncology, vol. 18, no. 4, pp. 813–823, 2000. View at Google Scholar · View at Scopus
  25. N. S. Kadan-Lottick, K. K. Ness, S. Bhatia, and J. G. Gurney, “Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia,” Journal of the American Medical Association, vol. 290, no. 15, pp. 2008–2014, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Bhatia, H. Sather, J. Zhang, M. Trigg, P. Gaynon, and L. Robison, “Ethnicity and survival following childhood acute lymphoblastic leukemia (ALL): follow-up of the children’s cancer group (CCG) cohort,” American Society of Clinical Oncology, vol. 18, abstract 2190, 1999. View at Google Scholar
  27. D. B. Lewis and C. B. Wilson, “Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection,” in Diseases of the Fetus and Newborn Infant, J. S. Remington and J. O. Klein, Eds., pp. 25–138, W. B. Saunders Company, Philadelphia, PA, USA, 5th edition, 2001. View at Google Scholar
  28. G. P. Dunn, L. J. Old, and R. D. Schreiber, “The three Es of cancer immunoediting,” Annual Review of Immunology, vol. 22, pp. 329–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C. H. Pui, F. G. Behm, W. M. Crist et al., “Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia,” Blood, vol. 82, no. 2, pp. 343–362, 1993. View at Google Scholar · View at Scopus